Detalhe da pesquisa
1.
Complement factors B, D, C3bBbP and risk of future venous thromboembolism.
Clin Immunol
; 249: 109278, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894046
2.
Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.
J Intern Med
; 292(3): 523-535, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426199
3.
Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.
Blood
; 136(16): 1863-1870, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645137
4.
Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity.
J Thromb Haemost
; 22(5): 1463-1474, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266680
5.
A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation.
J Thromb Haemost
; 20(4): 866-876, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34822223
6.
Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism.
J Thromb Haemost
; 20(4): 899-908, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000275
7.
Effect of lower-leg trauma and knee arthroscopy on procoagulant phospholipid-dependent activity.
Res Pract Thromb Haemost
; 6(4): e12729, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702586
8.
Plasma procoagulant phospholipid clotting time and venous thromboembolism risk.
Res Pract Thromb Haemost
; 5(8): e12640, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34977449
9.
Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
Thromb Res
; 208: 121-126, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763296
10.
Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.
J Thromb Haemost
; 17(6): 934-943, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30920726
11.
"A rapid, sensitive, and specific assay to measure tissue factor activity based on chromogenic determination of thrombin generation": reply.
J Thromb Haemost
; 21(4): 1062-1063, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990516
12.
Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis.
Sci Rep
; 8(1): 17216, 2018 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30464183
13.
Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.
Thromb Res
; 169: 50-56, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30015228
14.
Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry.
Circ Genom Precis Med
; 11(12): e002170, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30562114
15.
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.
Thromb Res
; 136(3): 566-72, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235746
16.
Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.
PLoS One
; 9(8): e105929, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25157856